The IPO of Cuprina Holdings (Cayman) Limited is a significant event as it marks the company's entry into the public market. The pricing of shares between $4.00 and $4.50 suggests a moderate valuation, and the 180-day lock-up period indicates a standard approach to insider trading restrictions. The company's focus on biomedical and biotechnology products could attract investors interested in these sectors, potentially driving up demand and the stock price in the short term.